LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

Background: Imatinib has become first line therapy in chronic myeloid leukemia patients. Little is known about the infective consequences during the treatment with this drug in large series of chronic phase patients. Material and methods: From January 2001 to September 2006 we treated with imatini...

詳細記述

書誌詳細

出版年:	Mediterranean Journal of Hematology and Infectious Diseases
主要な著者:	Massimo Breccia, Corrado Girmenia, Roberto Latagliata, Giuseppina Loglisci, Michelina Santopietro, Vincenzo Federico, Luigi Petrucci, Alessandra Serrao, Adriano Salaroli, Giuliana Alimena
フォーマット:	論文
言語:	英語
出版事項:	PAGEPress Publications 2011-05-01
主題:	chronic myeloid leukemia, imatinib, infections, bacterial, herpes Zoster
オンライン･アクセス:	http://www.mjhid.org/index.php/mjhid/article/view/303